VNDA

VNDA

Vanda Pharmaceuticals Inc. Common Stock

$4.590+-0.000 (-0.000%)

Preço em tempo real

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$4.590

Máximo

$4.590

Mínimo

$4.590

Volume

0.18M

Fundamentos da empresa

Estatísticas de negociação

Notícias relacionadas

PR Newswire

Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at the American Society of Clinical Psychopharmacology (ASCP) Annual...

Ver mais
Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting
PR Newswire

Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro &...

Ver mais
Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025
Analyst Upgrades

Cantor Fitzgerald Assumes Vanda Pharmaceuticals at Overweight, Announces Price Target of $13

Cantor Fitzgerald analyst Olivia Brayer assumes Vanda Pharmaceuticals with a Overweight rating and announces Price Target of $13.

Ver mais
Cantor Fitzgerald Assumes Vanda Pharmaceuticals at Overweight, Announces Price Target of $13
PR Newswire

Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the first quarter ended March 31, 2025....

Ver mais
Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.